291 related articles for article (PubMed ID: 17495473)
21. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
[TBL] [Abstract][Full Text] [Related]
22. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.
Lee BJ; Lee JG; Kim YH
J Psychopharmacol; 2007 Jun; 21(4):421-7. PubMed ID: 17092979
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic standards in Alzheimer disease.
Doody RS
Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S20-6. PubMed ID: 10622675
[TBL] [Abstract][Full Text] [Related]
24. Donepezil in the treatment of mild to moderate Alzheimer's disease: report of a Belgian multicenter study.
Santens P; Ventura M
Acta Neurol Belg; 2003 Sep; 103(3):159-63. PubMed ID: 14626696
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
Burns A; Gauthier S; Perdomo C
Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
[TBL] [Abstract][Full Text] [Related]
26. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
27. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
[TBL] [Abstract][Full Text] [Related]
28. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?
Tinklenberg JR; Kraemer HC; Yaffe K; Ross L; Sheikh J; Ashford JW; Yesavage JA; Taylor JL
Am J Geriatr Psychiatry; 2007 Nov; 15(11):953-60. PubMed ID: 17974866
[TBL] [Abstract][Full Text] [Related]
29. Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation.
Anzellotti F; Bonanni L; Iorio E; Di Baldassarre F; D'Andreagiovanni A; Monaco D; Thomas A; Onofrj M
Clin Neuropharmacol; 2008; 31(4):231-7. PubMed ID: 18670247
[TBL] [Abstract][Full Text] [Related]
30. No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia.
Kohler CG; Martin EA; Kujawski E; Bilker W; Gur RE; Gur RC
Cogn Neuropsychiatry; 2007 Sep; 12(5):412-21. PubMed ID: 17690999
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
[TBL] [Abstract][Full Text] [Related]
32. Changes in cognitive functions of patients with dementia of the Alzheimer type following long-term administration of donepezil hydrochloride: relating to changes attributable to differences in apolipoprotein E phenotype.
Kanaya K; Abe S; Sakai M; Fujii H; Iwamoto T
Geriatr Gerontol Int; 2010 Jan; 10(1):25-31. PubMed ID: 20102379
[TBL] [Abstract][Full Text] [Related]
33. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
[TBL] [Abstract][Full Text] [Related]
34. Effects of donepezil on verbal memory after semantic processing in healthy older adults.
FitzGerald DB; Crucian GP; Mielke JB; Shenal BV; Burks D; Womack KB; Ghacibeh G; Drago V; Foster PS; Valenstein E; Heilman KM
Cogn Behav Neurol; 2008 Jun; 21(2):57-64. PubMed ID: 18541979
[TBL] [Abstract][Full Text] [Related]
35. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.
Jones RW; Kivipelto M; Feldman H; Sparks L; Doody R; Waters DD; Hey-Hadavi J; Breazna A; Schindler RJ; Ramos H;
Alzheimers Dement; 2008 Mar; 4(2):145-53. PubMed ID: 18631958
[TBL] [Abstract][Full Text] [Related]
36. Neuropsychological test performance in healthy volunteers before and after donepezil administration.
Beglinger LJ; Gaydos BL; Kareken DA; Tangphao-Daniels O; Siemers ER; Mohs RC
J Psychopharmacol; 2004 Mar; 18(1):102-8. PubMed ID: 15107192
[TBL] [Abstract][Full Text] [Related]
37. Do vascular lesions and related risk factors influence responsiveness to donepezil chloride in patients with Alzheimer's disease?
Fukui T; Taguchi S
Dement Geriatr Cogn Disord; 2005; 20(1):15-24. PubMed ID: 15832031
[TBL] [Abstract][Full Text] [Related]
38. Clock drawing interpretation scale (CDIS) and neuro-psychological functions in older adults with mild and moderate cognitive impairments.
Colombo M; Vaccaro R; Vitali SF; Malnati M; Guaita A
Arch Gerontol Geriatr; 2009; 49 Suppl 1():39-48. PubMed ID: 19836615
[TBL] [Abstract][Full Text] [Related]
39. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.
Feldman HH; Schmitt FA; Olin JT;
Alzheimer Dis Assoc Disord; 2006; 20(4):263-8. PubMed ID: 17132971
[TBL] [Abstract][Full Text] [Related]
40. Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer?
Vellas B; Andrieu S; Cantet C; Dartigues JF; Gauthier S
J Nutr Health Aging; 2007; 11(4):338-41. PubMed ID: 17653494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
